Yoshiyuki Narahara
Chiba, 2701694, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Usefulness of portal vein pressure for predicting the effects of tolvaptan in cirrhotic patients.
Journal: World journal of gastroenterology
Published: February 23, 2016
Effect of fluvastatin on 24-week telaprevir-based combination therapy for hepatitis C virus genotype 1b-infected chronic hepatitis C.
Journal: European journal of gastroenterology & hepatology
Published: April 16, 2014
Management of gastric varices unsuccessfully treated by balloon-occluded retrograde transvenous obliteration: long-term follow-up and outcomes.
Journal: TheScientificWorldJournal
Published: October 20, 2013
Serum 25-hydroxyvitamin D3 levels affect treatment outcome in pegylated interferon/ribavirin combination therapy for compensated cirrhotic patients with hepatitis C virus genotype 1b and high viral load.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: October 11, 2013
Efficacy of Alfacalcidol on PEG-IFN/ Ribavirin Combination Therapy for Elderly Patients With Chronic Hepatitis C: A Pilot Study.
Journal: Hepatitis monthly
Published: September 15, 2013
Effects of fasudil on the portal and systemic hemodynamics of patients with cirrhosis.
Journal: Journal of gastroenterology and hepatology
Published: August 02, 2013
Predictive factors for improvement of ascites after transjugular intrahepatic portosystemic shunt in patients with refractory ascites.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: February 07, 2013
Lead-in treatment with interferon-β/ribavirin may modify the early hepatitis C virus dynamics in pegylated interferon alpha-2b/ribavirin combination for chronic hepatitis C patients with the IL28B minor genotype.
Journal: Journal of gastroenterology and hepatology
Published: November 14, 2012
Combination of fluvastatin with pegylated interferon/ribavirin therapy reduces viral relapse in chronic hepatitis C infected with HCV genotype 1b.
Journal: Journal of gastroenterology and hepatology
Published: August 22, 2012
An open-label randomized controlled study of pegylated interferon/ribavirin combination therapy for chronic hepatitis C with versus without fluvastatin.
Journal: Journal of viral hepatitis
Published: August 07, 2012
Effects of transjugular intrahepatic portosystemic shunt on changes in the small bowel mucosa of cirrhotic patients with portal hypertension.
Journal: Journal of gastroenterology
Published: May 24, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026